CD274 and neoplasm: Tumor cells often escape cytotoxic T lymphocyte destruction by the upregulation of immune checkpoint ligands, such as PD-L1, which can inhibit lymphocyte activation by binding to the complementary receptor (PD-1) on cytotoxic T lymphocytes.